about
Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound systemA simple method for determining the coagulation threshold temperature of transparent tissue-mimicking thermal therapy gel phantoms: Validated by magnetic resonance imaging thermometry.Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostateQuantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study.Characterization of nonlinear ultrasound fields of 2D therapeutic arraysLow intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG.MatMRI and MatHIFU: software toolboxes for real-time monitoring and control of MR-guided HIFU.Safety limitations of MR-HIFU treatment near interfaces: a phantom validation.Characterization of a multi-element clinical HIFU system using acoustic holography and nonlinear modelingMagnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermiaImage-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model.Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasoundThermochromic tissue-mimicking phantom for optimisation of thermal tumour ablation.Acoustic field characterization of a clinical magnetic resonance-guided high-intensity focused ultrasound system inside the magnet bore.Evaluation of a tissue-mimicking thermochromic phantom for radiofrequency ablation.Volumetric MR-HIFU ablation of uterine fibroids: role of treatment cell size in the improvement of energy efficiency.Magnetic Resonance-Guided Drug Delivery.Correcting heat-induced chemical shift distortions in proton resonance frequency-shift thermometry.Preclinical MRI-Guided Focused Ultrasound: A Review of Systems and Current Practices.Investigation of the stress response to mechanical versus thermal non-ablative focused ultrasound therapy in three in vivo murine cancer models.Boiling histotripsy method to mechanically fractionate tissue volumes in ex vivo bovine liver using a clinical MR-guided HIFU system.Evaluation and selection of anatomic sites for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy volunteer study.Comparison of Noninvasive High-Intensity Focused Ultrasound with Radiofrequency Ablation of Osteoid Osteoma.Initial investigation of a novel noninvasive weight loss therapy using MRI-Guided high intensity focused ultrasound (MR-HIFU) of visceral fat.Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU system.Magnetic Resonance Imaging-guided High-intensity Focused Ultrasound Applications in Pediatrics: Early Experience at Children's National Medical Center.Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.Feasibility of targeting canine soft tissue sarcoma with MR-guided high-intensity focused ultrasoundComputational modeling of high-intensity focused ultrasound mediated drug deliveryTissue-mimicking thermochromic phantom for characterization of HIFU devices and applications
P50
Q30359377-558F5648-D093-44D8-8529-A03428900244Q30362358-4822577F-1420-4CA4-9C50-FFDF9BA3333BQ30363260-09CB7938-6B68-4FCA-87AB-74D1A9C0FD67Q30394267-AF527B56-2EC4-42EF-8432-A0FC72FCAC99Q30397585-6B595419-66C8-462F-94E3-5FF025BAA7D1Q30406581-1F9DACEB-5B61-4376-BD5A-1590F02FE336Q30420792-3083E7D7-3998-428A-87B5-6F45EF86133DQ30422909-F44610B6-396A-486B-BC73-70F525AEB69AQ30425450-4791FA58-2BF3-4565-869E-37C575019735Q30433080-D372EFA8-44DD-4109-8B15-E51870E8BD31Q30433561-A27A6A92-0889-4992-A7F3-64A16F64803FQ30445172-38FF4FBA-DA2C-4AF6-ABBF-0FA39EF92DA7Q30456019-B3339BD5-3590-4387-99C6-0E7B11E8C806Q30462775-3AB7C2E0-5F8F-4A98-B6D0-361928CDCB8AQ30464743-6F9C90DF-0A4F-4263-95DE-3CB5A8976BEFQ35995337-9C69EC07-015C-4BD3-8066-62D2679AACB3Q36408692-51A3DE98-A0D3-4D80-B790-FFDC7F6B6BE0Q37017568-C80B35C2-2EFD-430E-87D8-2191429D98EAQ37940775-7ED33BCB-82B9-4AA3-8FF2-C46817ACE80EQ38616007-2C7A45F1-C6E5-40F1-98FF-4571E2AB6E57Q38619038-4CE37831-45FD-4C0B-BB99-1B3F8876DCC8Q38962915-4DF58982-A62B-4657-B330-25F8A0E04195Q45907949-614B8BAF-C4AE-40ED-BB7E-62C55E7B4565Q45909916-44D3B489-2D6D-41E2-825F-3FA82FD33584Q47200147-F5ABA86E-3EF2-446E-B538-11977CD18487Q47261686-F950576A-2657-4192-8430-E71874689AF5Q47367969-35193AD9-7808-494E-BA25-E149F5192B50Q47723700-2CB74269-028B-408F-93E2-97B66D02304EQ47762085-BB2815EC-539C-4680-BDF6-54B0F2A0367BQ50048736-23210329-A1E9-4FA1-92F0-E511F5CE9063Q50059812-E0E38581-40AB-425B-AD16-9E6195535F05Q50245200-A5C0A66C-6088-4579-BCFB-BD8C4086D2E7Q57284161-D5E410CD-F0B7-4686-9621-D6B41CC3E3B0Q57317529-6C259561-34DB-4F81-A4B7-C5CB6F2ACB03Q91697333-6B95AE3F-89BE-4B7D-894D-CB301FB32748
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ari Partanen
@ast
Ari Partanen
@en
Ari Partanen
@es
Ari Partanen
@nl
Ari Partanen
@sl
type
label
Ari Partanen
@ast
Ari Partanen
@en
Ari Partanen
@es
Ari Partanen
@nl
Ari Partanen
@sl
prefLabel
Ari Partanen
@ast
Ari Partanen
@en
Ari Partanen
@es
Ari Partanen
@nl
Ari Partanen
@sl
P106
P21
P31
P496
0000-0003-1985-149X
P569
2000-01-01T00:00:00Z